News | July 08, 2021
RDIF and Morepen announce production of test batch of Sputnik V
The first batch will be shipped to the Gamaleya Center for the quality control
The first batch will be shipped to the Gamaleya Center for the quality control
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Financial support is being provided as a grant from the Government of India
Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
These media reports are based on incorrect facts and are without any basis.
The country has constantly worked with the spirit of public-private partnership
The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021.
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Subscribe To Our Newsletter & Stay Updated
